(246 days)
Vitrea View software is a medical image viewing and information distribution that provides access, through the internet and within the enterprise to multi-modality softcopy medical images (including mammography and digital breast tomosynthesis), reports, and other patient-related information. This data is hosted within disparate archives and repositories for diagnosis, review, communication, and reporting of DICOM and non-DICOM data.
Lossy compressed mammography images and digitized film screen images must not be reviewed for primary image interpretations. Mammographic images may only be interpreted using an FDA cleared display that meets technical specifications reviewed and accepted by FDA or displays accepted by the appropriate regulatory agency for the country in which it is used.
Display monitors used for reading medical images for diagnostic purposes must comply with the applicable regulatory approvals and quality control requirements for their use and maintenance.
Vitrea View software is indicated for use by qualified healthcare professionals including, but not restricted to. radiologists, non-radiology specialists, physicians and technologists.
When accessing Vitrea View software from a mobile device, images viewed are for informational purposes only and not intended for diagnostic use.
The Vitrea View software is a web-based, cross-platform, zero-footprint enterprise image viewer solution capable of displaying both DICOM and non-DICOM medical images. The Vitrea View software enables clinicians and other medical professionals to access patients' medical images with integrations into a variety of medical record systems, such as Electronic Health Record (EHR), Electronic Medical Record (EMR), Health Information Exchange (HIE), Personal Health Record (PHR), and image exchange systems. The Vitrea View software is a communication tool, which supports the physician in the treatment and planning process by delivering access to images at the point of care.
The Vitrea View software offers medical professionals an enterprise viewer for accessing imaging data in context with reports from enterprise patient health information databases, fosters collaboration, and provides workflows and interfaces appropriate for referring physicians and clinicians. IT departments will not have to install client systems, due to the web-based zero-footbrint nature of the Vitrea View software. The Virea View software offers scalability to add new users as demand grows, and may be deployed in a virtualized environment. Some of the general features include:
. Fast time-to-first-image
- Contextual launch integration with single-sign-on
- . Easy study navigation and search capability
- Supports multi-modality vendor-neutral DICOM images
- . Supports non-DICOM images
- lmages display at full diagnostic quality (with appropriate hardware)
- . Basic 2D review tools (zoom, pan, measure)
- Basic 3D and MPR viewing
- Radiology key images
- . Comparative side-by-side review, regardless of image types
- . Collaboration tools
- . Leverages traditional DICOM as well as next-generation DICOMweb image transfer protocols
- Enables federated access to across multiple data sources across multiple sites
- . Web-based zero-footprint architecture
- Secure Access on various Windows® and Mac computers through standard internet
- browsers
- . Secure Access on various iOS®, Android™, and Windows® tablet devices through the device's Internet browser
- . Secure Access on various iOS and Android smartphones through the device's Internet browser
Here's the analysis of the acceptance criteria and the study that proves the device meets them, based on the provided text:
Device Name: Vitrea View
510(k) Number: K163232
1. Table of Acceptance Criteria and Reported Device Performance:
| Acceptance Criteria (from Radiologists' Rating) | Reported Device Performance (Vitrea View vs. Reference System) |
|---|---|
| Visualization of the adipose and fibroglandular tissue | Met clinical equivalence for diagnostic quality |
| Visualization of the breast tissue and underlying pectoralis muscle | Met clinical equivalence for diagnostic quality |
| Image contrast for differentiation of subtle tissue density differences | Met clinical equivalence for diagnostic quality |
| Sharpness, assessment of the edges of fine linear structures, tissue borders and benign calcifications | Met clinical equivalence for diagnostic quality |
| Tissue visibility at the skin line | Met clinical equivalence for diagnostic quality |
| Artifacts due to image processing, detector failure and other external factors to the breast | Met clinical equivalence for diagnostic quality |
| Overall clinical image quality | Met clinical equivalence for diagnostic quality |
2. Sample Size Used for the Test Set and Data Provenance:
- Mammography Image Quality Validation: 50 studies.
- Data Provenance: Studies were "chosen randomly from existing patient studies obtained over a two-day time-frame at the designated Breast Imaging center." This indicates retrospective data from a specific imaging center.
- Digital Breast Tomosynthesis Image Quality Validation: 50 studies.
- Data Provenance: Studies were "chosen randomly from existing patient studies obtained at the designated Breast Imaging center." This also indicates retrospective data from a specific imaging center.
3. Number of Experts Used to Establish Ground Truth for the Test Set and Qualifications of Those Experts:
- Mammography Image Quality Validation: Four experienced radiologists. No further specific qualifications (e.g., years of experience) are provided.
- Digital Breast Tomosynthesis Image Quality Validation: Three experienced radiologists. No further specific qualifications are provided.
4. Adjudication Method for the Test Set:
The studies were multi-reader, multi-case tests where radiologists were asked to rate image quality equivalence. The text states:
- "The radiologists found all of the images displayed met the clinical equivalence for diagnostic quality when displayed using the Vitrea View software as compared to the same studies displayed using the McKesson system."
- "The radiologists found all of the images displayed met the clinical equivalence for diagnostic quality when displayed using Vitrea View as compared to the same studies using the sites existing Phillips Radiology system."
This suggests a consensus or agreement among the radiologists was reached, rather than a formal adjudication method like a 2+1 or 3+1 rule. The criteria were rating the image quality on a scale of 1 to 3, but the specifics of how these individual ratings were combined or adjudicated to reach the overall "met clinical equivalence" conclusion are not detailed.
5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done, and the Effect Size of How Much Human Readers Improve with AI vs. Without AI Assistance:
Yes, MRMC studies were done for both mammography and digital breast tomosynthesis. However, these were not comparative effectiveness studies evaluating human reader improvement with AI assistance. Instead, they were image quality equivalence studies comparing the device's display quality against a cleared predicate/reference device. The purpose was to show that images displayed by "Vitrea View software... met the clinical equivalence for diagnostic quality" when compared to a reference system displaying the same images. Therefore, an effect size of human improvement with AI vs. without AI is not applicable to these studies.
6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Was Done:
No, the studies described were focused on the display quality of the Vitrea View software in conjunction with diagnostic monitors, for review by human radiologists. It was not a standalone algorithmic performance evaluation.
7. The Type of Ground Truth Used:
The ground truth was established by the subjective rating of "experienced radiologists" on the "overall clinical image quality" and other specific image quality parameters. This is effectively expert consensus on image quality and clinical equivalence for diagnostic use. It does not appear to involve pathology or outcomes data to define disease presence or absence.
8. The Sample Size for the Training Set:
The document does not specify a training set or its size. The studies described are verification and validation of the device's performance, not the training of a machine learning model.
9. How the Ground Truth for the Training Set Was Established:
Not applicable, as no training set or ground truth establishment for a training set is mentioned in the provided text.
{0}------------------------------------------------
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized image of three faces in profile, stacked on top of each other.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
July 21, 2017
Vital Images, Inc. % Fei Li Regulatory Affairs Specialist 5850 Opus Parkway, Suite 300 MINNETONKA MN 55343
Re: K163232 Trade/Device Name: Vitrea View Regulation Number: 21 CFR 892.2050 Regulation Name: Picture archiving and communications system Regulatory Class: II Product Code: LLZ Dated: June 14, 2017 Received: June 15, 2017
Dear Fei Li:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21. Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041
{1}------------------------------------------------
or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely,
Michael D.'Hara For
Robert Ochs, Ph.D. Director Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
Indications for Use
510(k) Number (if known) K163232
Device Name Vitrea View
Indications for Use (Describe)
Vitrea View software is a medical image viewing and information distribution that provides access, through the internet and within the enterprise to multi-modality softcopy medical images (including mammography and digital breast tomosynthesis), reports, and other patient-related information. This data is hosted within disparate archives and repositories for diagnosis, review, communication, and reporting of DICOM and non-DICOM data.
Lossy compressed mammography images and digitized film screen images must not be reviewed for primary image interpretations. Mammographic images may only be interpreted using an FDA cleared display that meets technical specifications reviewed and accepted by FDA or displays accepted by the appropriate regulatory agency for the country in which it is used.
Display monitors used for reading medical images for diagnostic purposes must comply with the applicable regulatory approvals and quality control requirements for their use and maintenance.
Vitrea View software is indicated for use by qualified healthcare professionals including, but not restricted to. radiologists, non-radiology specialists, physicians and technologists.
When accessing Vitrea View software from a mobile device, images viewed are for informational purposes only and not intended for diagnostic use.
Type of Use (Select one or both, as applicable)
| Prescription Use (Part 21 CFR 801 Subpart D) |
|---|
| Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
{3}------------------------------------------------
Image /page/3/Picture/1 description: The image shows the word "ViTAL" in all caps. The letters are black, except for the dot on the "i", which is red. The font is sans-serif and the letters are evenly spaced.
510K Summary
This 510(k) summary is submitted in accordance with the requirements of 21 C.F.R. Part 807.92(c).
| Basis for the Submission: | Vital Images, Inc. hereby submits this traditional 510(k) to obtain510(k) clearance for the Vitrea View software which we believe issubstantially equivalent to the FDA cleared VitreaView (K150738). |
|---|---|
| Submitter: | Vital Images, Inc.5850 Opus Parkway, Suite 300Minnetonka, MN, 55343-4414 |
| Establishment Registration: | 2134213 |
| Contact Person: | Fei LiRegulatory Affairs SpecialistPhone : 952-487-9539Fax: 952-487-9510E-mail: fli@vitalimages.comAlternate Contact Person:Vince SwensonSr. Director of Quality and RegulatoryPhone: 952-487-9548Fax: 952-487-9510E-mail: vswenson@vitalimages.com |
| 510(k) Type: | Traditional |
| Summary Date: | November 16, 2016 |
| Device Trade Name: | Vitrea View |
| Device Common Name/ Regulatory Description: | Picture Archiving and Communications System |
| Device Classification Name: | System, Image Processing, Radiological |
| Regulation Number: | 21 CFR 892.2050 |
| Product Code: | LLZ |
| Regulatory Classification: | Class II |
| Device Panel: | Radiology |
{4}------------------------------------------------
Image /page/4/Picture/0 description: The image shows the word "VITAL" in black letters. The "i" in "VITAL" has a red dot above it, resembling a candle flame. The font is sans-serif and the letters are evenly spaced.
Predicate Device(s):
| Predicate Device | Manufacturer | FDA 510(k) Number |
|---|---|---|
| VitreaView | Vital Images, Inc.5850 Opus Parkway, Suite 300,Minnetonka, Minnesota 55343 U.S.A. | K150738 |
Reference Device(s):
| Reference Device | Manufacturer | FDA 510(k) Number |
|---|---|---|
| McKesson Radiology | McKesson Medical Imaging Company5995 Winward ParkwayAlpharetta, GA 30005 | K140909 |
| Phillips IntellispaceRadiology system | Philips Healthcare Informatics, Inc.4100 E 3rd Ave Ste 101Foster City, CA 94404 | K111804 |
Device Description:
The Vitrea View software is a web-based, cross-platform, zero-footprint enterprise image viewer solution capable of displaying both DICOM and non-DICOM medical images. The Vitrea View software enables clinicians and other medical professionals to access patients' medical images with integrations into a variety of medical record systems, such as Electronic Health Record (EHR), Electronic Medical Record (EMR), Health Information Exchange (HIE), Personal Health Record (PHR), and image exchange systems. The Vitrea View software is a communication tool, which supports the physician in the treatment and planning process by delivering access to images at the point of care.
The Vitrea View software offers medical professionals an enterprise viewer for accessing imaging data in context with reports from enterprise patient health information databases, fosters collaboration, and provides workflows and interfaces appropriate for referring physicians and clinicians. IT departments will not have to install client systems, due to the web-based zero-footbrint nature of the Vitrea View software. The Virea View software offers scalability to add new users as demand grows, and may be deployed in a virtualized environment. Some of the general features include:
. Fast time-to-first-image
- Contextual launch integration with single-sign-on ●
- . Easy study navigation and search capability
- Supports multi-modality vendor-neutral DICOM images
- . Supports non-DICOM images
- lmages display at full diagnostic quality (with appropriate hardware) ●
- . Basic 2D review tools (zoom, pan, measure)
- Basic 3D and MPR viewing ●
- Radiology key images
- . Comparative side-by-side review, regardless of image types
- . Collaboration tools
- . Leverages traditional DICOM as well as next-generation DICOMweb image transfer protocols
- Enables federated access to across multiple data sources across multiple sites ●
- . Web-based zero-footprint architecture
- Secure Access on various Windows® and Mac computers through standard internet ● browsers
- . Secure Access on various iOS®, Android™, and Windows® tablet devices through the device's Internet browser
{5}------------------------------------------------
Image /page/5/Picture/0 description: The image shows the word "VITAL" in black font. The "i" in "VITAL" has a red dot above it, resembling a flame. The font is simple and sans-serif, and the letters are evenly spaced.
- . Secure Access on various iOS and Android smartphones through the device's Internet browser
Intended Use / Indications for Use:
Vitrea View software is a medical image viewing and information application that provides access, through the internet and within the enterprise to multi-modality softcopy medical images (including mammography and digital breast tomosynthesis), reports, and other patient-related information. This data is hosted within disparate archives and repositories for diagnosis, review, communication, and reporting of DICOM and non-DICOM data.
Lossy compressed mammography images and digitized film screen images must not be reviewed for primary image interpretations. Mammographic images may only be interpreted using an FDA cleared display that meets technical specifications reviewed and accepted by FDA or displays accepted by the appropriate regulatory agency for the country in which it is used.
Display monitors used for reading medical images for diagnostic purposes must comply with the applicable requlatory approvals and quality control requirements for their use and maintenance.
Vitrea View software is indicated for use by qualified healthcare professionals including, but not restricted to, radiologists, non-radiology specialists, physicians and technologists.
When accessing Vitrea View software from a mobile device, images viewed are for informational purposes only and not intended for diagnostic use.
Intended for Disease / Condition / Patient Population:
Vitrea View software is a medical image viewer software. Therefore, specific information on the intended disease, condition, and patient population is not applicable.
Key Changes from the last 510(k) clearance K150738
Kev Changes include:
- Support for diagnostic viewing of mammographic images and digital breast tomography ● images
- . Enhancements in the administration and support of the product
- Ability to allow clinicians to collaborate on images, information, and artifacts related to the ● imaging studies using the Vitrea View software
- User Centric enhancements
- Performance Improvements
- Licensing enhancements
- Better integration with EMRs by supporting more targeted searchers within the launch and history search APIs
- . Ability to record information of users who accessed the Vitrea View software and which studies they viewed
- . Add support for Breast Tomography SOP class
- . Support for SQL Server 2014
- Improvements in connectivity to archives including PACS, VNA and DICOMWeb .
- . View the UDI for Vitrea View identification
{6}------------------------------------------------
ViTAL
Substantial Equivalence Comparison:
Regulatory Comparison:
| Characteristic | Subject Device | Predicate Device | |
|---|---|---|---|
| Vitrea View | VitreaView(K150738) | Comparison | |
| Classification Name | Picture ArchivingandCommunicationsSystem | Picture ArchivingandCommunicationsSystem | Same |
| Regulatory Number | 892.2050 | 892.2050 | Same |
| Product Code | LLZ | LLZ | Same |
| Classification | Class II | Class II | Same |
| Review Panel | Radiology | Radiology | Same |
| Decision Date | TBD | April 6, 2015 | Predicate device iscleared |
Indications for Use Comparison with Predicate Device:
| Subject Device | Predicate Device | |||
|---|---|---|---|---|
| Criteria | Vitrea View | VitreaView (K150738) | Comparison | |
| Indications for Use | Vitrea View software isa medical imageviewing andinformation distributionapplication thatprovides access,through the internetand within theenterprise to multi-modality softcopymedical images(includingmammography anddigital breasttomosynthesis),reports, and otherpatient-relatedinformation. This datais hosted withindisparate archives andrepositories fordiagnosis, review,communication, andreporting of DICOMand non-DICOM data. | VitreaView is amedical image viewingand informationdistribution applicationthat provides access,through the internetand within theenterprise to multi-modality softcopymedical images,reports, and otherpatient-relatedinformation. This datais hosted withindisparate archives andrepositories fordiagnosis, review,communication, andreporting of DICOMand non-DICOM data.Display monitors usedfor reading medicalimages for diagnosticpurposes must complywith the applicableregulatory approvalsand quality control | SimilarAdded support forVitrea View to be usedfor diagnostic viewingof mammographicimages and digitalbreast tomographyimages | |
| Lossy compressedmammography | ||||
| Criteria | Subject Device | Predicate Device | Comparison | |
| Vitrea View | VitreaView (K150738) | |||
| images and digitizedfilm screen imagesmust not be reviewedfor primary imageinterpretations.Mammographicimages may only beinterpreted using anFDA cleared displaythat meets technicalspecificationsreviewed andaccepted by FDA ordisplays accepted bythe appropriateregulatory agency forthe country in which itis used.Display monitors usedfor reading medicalimages for diagnosticpurposes must complywith the applicableregulatory approvalsand quality controlrequirements for theiruse and maintenance.Vitrea View software isindicated for use byqualified healthcareprofessionalsincluding, but notrestricted to,radiologists, non-radiology specialists,physicians andtechnologists.When accessingVitrea View softwarefrom a mobile device,images viewed are forinformational purposesonly and not intendedfor diagnostic use. | requirements for theiruse and maintenance.Lossy compressedmammographyimages and digitizedfilm screen imagesmust not be reviewedfor primary imageinterpretations.When accessingVitreaView from amobile device, imagesviewed are forinformational purposesonly and not intendedfor diagnostic use. | |||
| Intended Users | Qualified healthcareprofessionalsincluding, but notrestricted to, | Qualified healthcareprofessionalsincluding, but notrestricted to, | Same | |
| Criteria | Subject Device | Predicate Device | Comparison | |
| Vitrea View | Vitrea View (K150738) | |||
| radiologists, non-radiology specialists,physicians andtechnologists. | radiologists, non-radiology specialists,physicians andtechnologists. | |||
| Patient Population | Vitrea View software isa medical imageviewer software.Therefore, specificinformation on theintended disease,condition, and patientpopulation is notapplicable. | VitreaView is amedical image viewersoftware. Therefore,specific information onthe intended disease,condition, and patientpopulation is notapplicable. | Same | |
| Modality Support | Multi-modality | Multi-modality | Same | |
| Criteria | Description | Subject DeviceVitrea View | Predicate DeviceVitreaView(K150738) | Comparison |
| Annotation andMeasurementTools | • Line• Angle• Ruler• Arrow | Yes | Yes | Same |
| User InstallationRequirements | • Runs within browserusing HTML andJavaScript only• No installation isrequired on user'smachine | Yes | Yes | Same |
| Data TypeSupported | • DICOM• Non-DICOM | Yes | Yes | Same |
| Image View/Manipulation | • Image Zoom• Pan• Window Level• Auto WindowLevel• Reset• Scout Lines• Image Rotate• Image Flip• Magnify• Image Invert• Image Cine | Yes | Yes | Same |
| Data Encryption | • HTTPS• SSL | Yes | Yes | Same |
| PatientDemographicDisplay | Capable of displayingpatient demographicinformation | Yes | Yes | Same |
| Linking | Co-planar linking:• Autolink• Manual | Yes | Yes | Same |
| User andPasswordControl | Users can be managedvia an internaldatabase, activedirectory, or parentapplication | Yes | Yes | Same |
| Data SecurityAudit Trail | Stored on serverAudit trail logged | YesYes | YesYes | SameSame |
| Criteria | Description | Subject DeviceVitrea View | Predicate DeviceVitrea View(K150738) | Comparison |
| UserManagement | Database structureallows mapping users togroups internally ormapping externalgroups (AD, parentapplication) to internalgroups and role | Yes | Yes | Same |
| TransmissionModes | Via the web withInternet browsers | Yes | Yes | Same |
| File Type Used | JPEG for Lossy data PNG for Lossless data | Yes | Yes | Same |
| MPR Viewing | This viewing featureenables the display ofreformatted CT and MRimages into axial,coronal and sagittalorientations. | Yes | Yes | Same |
| 3D VolumeRenderedViewing | This viewing featureenables the display of3D perspective views ofCT and MR image setsthat have beentransformed intovolumes. It alsoprovides presets toenable users to alter thevisualization parametersof the 3D views tohighlight features. | Yes | Yes | Same |
| Active TargetTool | This viewing featureprovides a facility toview a single targetlocation within multipleimages. | Yes | Yes | Same |
| CrosshairNavigation andSynchronization: | This viewing featureprovides a facility tosynchronize and scrollthrough multiple viewsat the same time. | Yes | Yes | Same |
| Ability to cloneimages side byside | Ability to clone imagesside by side. | Yes | Yes | Same |
| Criteria | Description | Subject DeviceVitrea View | PredicateDeviceVitrea View(K150738) | Comparison |
| Ability to closean image byclicking an "X”in the upper-leftportion of theviewport | Ability to close an imageby clicking an "X" in theupper-left portion of theviewport. | Yes | Yes | Same |
| Ability to selectlocale andlanguagesettings on thelogin screen | Ability to select localeand language settingson the login screen. | Yes | Yes | Same |
| Ability tocustomize thecolumns in thestudy directoryby selecting thedropdown arrowon the right sideof each column. | Ability to customize thecolumns in the studydirectory by selectingthe dropdown arrow onthe right side of eachcolumn. | Yes | Yes | Same |
| Help Tips | Proactive help tipsappear for 10-15seconds to educateusers on certainfunctionality that maynot be obvious to a newuser. | Yes | Yes | Same |
| Support for TIFFiles | Vitrea View can displayTIF files. | Yes | Yes | Same |
| Criteria | Description | Subject Device | Predicate Device | Comparison |
| Vitrea View | VitreaView(K150738) | |||
| Tabletsupport forinformationpurposeonly(Not fordiagnostic use) | This viewing featureprovides access ofVitrea View softwareon various iOS andAndroid tabletdevices through thedefault internetbrowser. Keyfeatures are:Two-finger pinch to zoom and pan Touch and drag to scroll Double-tap to access Gesture menu Tap Carousel thumbnail, then tap Image Pane to swap images Ambient Lighting Check | Yes | Yes | Same |
| Diagnosticquality medicalimage review | Ability to providediagnostic qualitymedical image reviewfor multi-dimensionaldigital images acquiredfrom a variety ofimaging devices | Yes | Yes | Same |
| Subject Device | Predicate Device | |||
| Criteria | Vitrea View | VitreaView(K150738) | Comparison | |
| Feature: Support for diagnosticviewing of mammographicimages and digital breasttomography images | Yes | No | Expanded theIndications for Useto include the abilityto allow viewing ofmulti-modalityimages (includingmammography anddigital breasttomosynthesis) forreview anddiagnosis whenused in conjunctionwith monitorscleared by the FDA,and viewed byappropriatelyqualified personnel. | |
| General Enhancements:(see below for detailed information) | The majority ofthese generalmodifications areenhancements topre-existingfunctionality orfeatures within thealready clearedVitreaView(K150738). Anynew functionalitydoes not alter thefundamentaltechnology anddoes not affect thesafety/effectiveness or theintended use forviewing multi-modality images. | |||
| • Enhancements in theadministration and supportof the product | Yes | No | ||
| • Ability to allow clinicians tocollaborate on images,information, and artifactsrelated to the imagingstudies using the VitreaView software | Yes | No | ||
| • User Centricenhancements | Yes | No | ||
| • PerformanceImprovements | Yes | No | ||
| • Licensing enhancements | Yes | No | ||
| • Better integration withEMRs by supporting moretargeted searchers withinthe launch and historysearch APIs | Yes | No | ||
| • Ability to record informationof users who accessed theVitrea View software andwhich studies they viewed | Yes | No | ||
| • Support for SQL Server2014 | Yes | No | ||
| Criteria | Subject Device | Predicate Device | ||
| Vitrea View | VitreaView(K150738) | Comparison | ||
| • Improvements inconnectivity to archivesincluding PACS, VNA andDICOMWeb | Yes | No | ||
| • View the UDI for VitreaView identification | Yes | No | ||
| • Add support for BreastTomography SOP class | Yes | No |
{7}------------------------------------------------
Image /page/7/Picture/0 description: The image shows the word "ViTAL" in a sans-serif font. The letters are black, except for the dot above the "i", which is red. The letters are evenly spaced and the word is centered.
Vitrea View Traditional 510(k) Pre-Market Notification
{8}------------------------------------------------
Image /page/8/Picture/0 description: The image shows the word "VITAL" in black letters. The "i" in "VITAL" has a red dot above it. The font is sans-serif and the letters are bold.
Vitrea View Traditional 510(k) Pre-Market Notification
{9}------------------------------------------------
Image /page/9/Picture/0 description: The image shows the word "ViTAL" in a sans-serif font. The letters are black, except for the dot above the "i", which is red. The letters are evenly spaced and the word is centered.
Similarities in Technology with the Predicate Device:
{10}------------------------------------------------
Image /page/10/Picture/0 description: The image shows the word "VITAL" in black font. The "i" in "VITAL" has a red dot above it. The font is sans-serif and appears to be a bold typeface. The background is white.
{11}------------------------------------------------
Image /page/11/Picture/0 description: The image shows the word "ViTAL" in a sans-serif font. The letters are black, except for the dot above the "i", which is red. The letters are evenly spaced and the word is horizontally aligned.
{12}------------------------------------------------
Image /page/12/Picture/0 description: The image shows the word "ViTAL" in a bold, sans-serif font. The letters are black, except for the dot above the "i", which is red. The letters are evenly spaced and aligned horizontally.
{13}------------------------------------------------
Image /page/13/Picture/0 description: The image shows the word "ViTAL" in a bold, sans-serif font. The letters are black, except for the dot above the "i", which is red. The letters are evenly spaced and the word is centered.
Differences in Technology with the Predicate Device:
{14}------------------------------------------------
Image /page/14/Picture/0 description: The image shows the word "ViTAL" in black letters. The "i" in "ViTAL" has a red dot above it. The letters are all capitalized except for the "i".
Similarities in Technology with the Reference Device
| Subject Device | Reference Device | Reference Device | ||
|---|---|---|---|---|
| Criteria | Vitrea View | McKessonRadiology(K140909)(Mammography) | PhillipsIntellispaceRadiologysystem(K111804)(Digital BreastTomosynthesis) | Comparison |
| Feature:Support fordiagnosticviewing ofmammographicimages | Yes | Yes | N/A | Same |
| Feature:Support fordiagnosticviewing ofdigital breasttomographyimages | Yes | N/A | Yes | Same |
| ClassificationName | Picture ArchivingandCommunicationsSystem | Picture ArchivingandCommunicationsSystem | Picture ArchivingandCommunicationsSystem | Same |
| RequlatoryNumber | 892.2050 | 892.2050 | 892.2050 | Same |
| Product Code | LLZ | LLZ | LLZ | Same |
| Classification | Class II | Class II | Class II | Same |
| Review Panel | Radiology | Radiology | Radiology | Same |
| Decision Date | TBD | July 2, 2014 | July 28, 2011 | Referencedevices arecleared |
| Indications forUse | Vitrea Viewsoftware is amedical image | McKessonRadiology™ ismedical image and | IntelliSpace PACS4.x is an imagemanagement | Similar |
| Subject Device | Reference Device | Reference Device | ||
| Criteria | Vitrea View | McKessonRadiology(K140909)(Mammography) | PhillipsIntellispaceRadiologysystem(K111804)(Digital BreastTomosynthesis) | Comparison |
| viewing and | information | system intended | ||
| information | management | to be used by | ||
| distribution | software that is | trained | ||
| application that | intended to | professionals. | ||
| provides access, | receive, transmit, | including but not | ||
| through the internet | store, archive, | limited to | ||
| and within the | retrieve, manage, | physicians, nurses | ||
| enterprise to multi- | display, print and | and medical | ||
| modality softcopy | process digital | technicians. | ||
| medical images | medical images, | |||
| (including | digital medical | The system is a | ||
| mammography and | video and | software package | ||
| digital breast | associated patient | used with general | ||
| tomosynthesis), | and medical | purpose | ||
| reports, and other | information. | computing | ||
| patient-related | McKesson | hardware to | ||
| information. This | Radiology includes | acquire, store, | ||
| data is hosted | a suite of | distribute, process | ||
| within disparate | standalone, web- | and display | ||
| archives and | enabled software | images and | ||
| repositories for | components, and | associated data | ||
| diagnosis, review, | is intended for | throughout a | ||
| communication, | installation and use | clinical | ||
| and reporting of | with off-the-shelf | environment. The | ||
| DICOM and non- | hardware that | software performs | ||
| DICOM data. | meets or exceeds | digital image | ||
| minimum | processing, | |||
| Lossy compressedmammography | specifications. | measurement,communication | ||
| images and | McKesson | and storage. | ||
| digitized film | Radiology | |||
| screen images | Station™ is the | Lossy compressed | ||
| must not be | primary software | mammographic | ||
| reviewed for | component used | images and | ||
| primary image | for processing and | digitized screen | ||
| interpretations. | presentation of | images must not | ||
| Mammographic | medical images on | be reviewed for | ||
| images may only | display devices | primary image | ||
| be interpreted | with network | interpretations. | ||
| using an FDA | access to | |||
| cleared display that | McKesson | Mammographic | ||
| meets technical | Radiology. | images may only | ||
| specifications | McKesson | be interpreted | ||
| reviewed and | Radiology Station | using an FDA | ||
| accepted by FDA | is intended to | approved monitor | ||
| Subject Device | Reference Device | Reference Device | ||
| Criteria | Vitrea View | McKessonRadiology(K140909)(Mammography) | PhillipsIntellispaceRadiologysystem(K111804)(Digital BreastTomosynthesis) | Comparison |
| or displaysaccepted by theappropriateregulatory agencyfor the country inwhich it is used.Display monitorsused for readingmedical images fordiagnosticpurposes mustcomply with theapplicableregulatoryapprovals andquality controlrequirements fortheir use andmaintenance.Vitrea Viewsoftware isindicated for use byqualified healthcareprofessionalsincluding, but notrestricted to,radiologists, non-radiologyspecialists,physicians andtechnologists.When accessingVitrea Viewsoftware from amobile device,images viewed arefor informationalpurposes only andnot intended fordiagnostic use. | process anddisplay losslessand non-losslesscompressedmedical imagesprovided fromDICOMconformantmodalities such asX-Ray | that offers at least5 Mpixel resolutionand meets othertechnicalspecificationsreviewed andaccepted by FDA. | ||
| Subject Device | Reference Device | Reference Device | ||
| Criteria | Vitrea View | McKessonRadiology(K140909)(Mammography) | PhillipsIntellispaceRadiologysystem(K111804)(Digital BreastTomosynthesis) | Comparison |
| McKessonRadiology isindicated for useby qualifiedhealthcareprofessionalsincluding, but notrestricted to,radiologists, non-radiologyspecialists,physicians andtechnologists. |
{15}------------------------------------------------
Image /page/15/Picture/0 description: The image shows the word "ViTAL" in a sans-serif font. The letters are black, except for the dot above the "i", which is red. The letters are evenly spaced and the word is centered.
{16}------------------------------------------------
Image /page/16/Picture/0 description: The image shows the word "ViTAL" in a sans-serif font. The letters are black, except for the dot above the "i", which is red. The letters are evenly spaced and the word is centered.
{17}------------------------------------------------
Image /page/17/Picture/0 description: The image shows the word "VITAL" in black letters. The "i" in "VITAL" has a red dot above it, resembling a flame. The font is sans-serif and the letters are evenly spaced.
Summary of Non-Clinical Tests:
The Vitrea View software was designed, developed, and tested according to IEC 62304:2006 standard for Medical Device Software Life Cycle Processes. Vital Images' internal Agile Development Processes is summarized in the Vital Images' Agile Product Development Process (SOP-301.150).
The following design control measures were applied to the development of the Vitrea View software:
- . Risk Management
- Software Requirements Reviews .
- Code Designs ●
- . Code Development Testing
- Code Reviews
- Design Reviews
- Verification of the software - that included performance and safety testing
- Validation of the software that included simulated usability testing by experienced ● professionals.
Risk Management:
Each risk pertaining to these features have been individually assessed to determine if the benefits outweigh the risk. Every risk has been reduced as low as possible and has been evaluated to have a probability of occurrence of harm of "Improbable." All risks for this feature were collectively reviewed to determine if the benefits outweigh the risk. Because of the risk control measures included in this feature, it is believed that the risk for the feature as a whole is extremely low. Taking into account all risks against the benefits of this feature, it has been assessed that the benefits do outweigh the risks for this feature.
During the design review, the following conclusions were reached:
- All risks were reduced as low as possible .
{18}------------------------------------------------
Image /page/18/Picture/0 description: The image shows the word "VITAL" in black letters. The "i" in "VITAL" has a red dot above it. The letters are bold and sans-serif.
- . The medical benefits of the device outweigh the residual risk for each individual risk and all risks together
- . The overall residual risk for the project is deemed acceptable
Verification and Validation:
The software was designed, developed, tested, verified, and validated according to written procedures. Verification confirmed that the feature functions according to its requirements.
Software testing was completed to ensure the Vitrea View software functions according to its requirements. Performance testing for the Vitrea View software included internal verification and external validation.
External validation was done to:
- a) Establish the substantial equivalence between the Vitrea View software with the McKesson Radiology system ((K140909) reference device) to modify the current Vitrea View software indications to include viewing of diagnostic mammography images.
- Establish the substantial equivalence between the Vitrea View software with the Phillips b) Intellispace Radiology system ((K111804) reference device) to modify the current Vitrea View software indications to include viewing of diagnostic digital breast tomography images.
a) Mammography Image Quality Validation
The validation was a multi-reader, multi-case test with four experienced radiologists reviewing Digital Mammography X-Ray Image Storage SOP class studies. The validation used the already cleared McKesson Radiology system (K140909) in association with WIDE PN21IQS monitors (K052312), side by side with the Vitrea View software displayed on Barco Coronis Fusion 10MP monitors (K133984).
Fifty studies were chosen randomly from existing patient studies obtained over a two-day time-frame at the designated Breast Imaging center. The radiologists were asked to rate the image quality equivalence of the Vitrea View software on a scale of 1 to 3 compared to the McKesson system for:
-
- Visualization of the adipose and fibroglandular tissue
-
- Visualization of the breast tissue and underlying pectoralis muscle
- Image contrast for differentiation of subtle tissue density differences 3.
- Sharpness, assessment of the edges of fine linear structures, tissue borders and benign 4. calcifications
-
- Tissue visibility at the skin line
- Artifacts due to image processing, detector failure and other external factors to the breast 6.
- Overall clinical image quality 7.
The radiologists found all of the images displayed met the clinical equivalence for diagnostic quality when displayed using the Vitrea View software as compared to the same studies displayed using the McKesson system.
b) Digital Breast Tomosynthesis Image Quality Validation
The validation was a multi-reader, multi-case test with three experienced radiologists reviewing Digital Breast Tomosynthesis Image SOP class studies. The validation used the already cleared Phillips Intellispace Radiology system (K111804) in association with Barco Nio 5MP MDCG-5221 monitors (K133984), side by side with the Vitrea View software displayed on Barco Mammo Tomosynthesis 5 MegaPixel MDMG-5221 monitors (K161229).
Fifty studies were chosen randomly from existing patient studies obtained at the designated Breast Imaging center. The radiologists were asked to rate the image quality equivalence of the Vitrea View software on a scale of 1 to 3 compared to the Phillips Intellispace Radiology system for:
{19}------------------------------------------------
Image /page/19/Picture/0 description: The image shows the word "VITAL" in black letters. The "i" in "VITAL" has a red dot above it. The font is sans-serif and the letters are bold.
- Visualization of the adipose and fibroglandular tissue 1.
-
- Visualization of the breast tissue and underlying pectoralis muscle
- Image contrast for differentiation of subtle tissue density differences 3.
-
- Sharpness, assessment of the edges of fine linear structures, tissue borders and benign calcifications
-
- Tissue visibility at the skin line
-
- Artifacts due to image processing, detector failure and other external factors to the breast
-
- Overall clinical image quality
The radiologists found all of the images displayed met the clinical equivalence for diagnostic quality when displayed using Vitrea View as compared to the same studies using the sites existing Phillips Radiology system.
Overall, the testing performed on the Vitrea View software confirmed the software functions according to its requirements, conforms to the intended use and is safe and effective.
Summary of Clinical Tests:
The subject of this 510(k) notification, Vitrea View software, did not require clinical studies to support safety and effectiveness of the software.
Cyber and Information Security
Vitrea View software follows internal documentation which includes information based on the FDA Guidance: Content of Premarket Submissions for Management of Cybersecurity in Medical Devices.
Internal documentation covers the following:
-
- Hazard analysis, mitigations, and design considerations pertaining to intentional and unintentional cybersecurity risks associated with your device, including:
- A specific list of all cybersecurity risks that were considered in the design of your ● device:
- A specific list and justification for all cybersecurity controls that were established for vour device.
- A traceability matrix that links your actual cybersecurity controls to the cybersecurity risks that 2. were considered;
-
- A summary describing the plan for providing validated software updates and patches as needed throughout the lifecycle of the medical device to continue to assure its safety and effectiveness. The FDA typically will not need to review or approve medical device software changes made solely to strengthen cybersecurity.
-
- A summary describing controls that are in place to assure that the medical device software will maintain its integrity (e.q. remain free of malware) from the point of origin to the point at which that device leaves the control of the manufacturer; and
-
- Device instructions for use and product specifications related to recommended cybersecurity controls appropriate for the intended use environment (e.g. anti-virus software, use of firewall).
{20}------------------------------------------------
Image /page/20/Picture/1 description: The image shows the word "VITAL" in black font. The "i" in "VITAL" has a red dot above it. The font is sans-serif and the letters are evenly spaced.
Performance Standards:
The FDA has not established mandatory performance standards and no special controls exist for this device. General software verification and validation tests were conducted to confirm proper function of the device's features.
The Virea View software complies with the following voluntary recognized consensus standards:
| Standard No. | StandardsOrganization | Standard Title | Version | Date |
|---|---|---|---|---|
| PS 3.1- 3.20 (2011)(RecognitionNumber 12-238) | NEMA | Digital Imaging andCommunications in Medicine(DICOM) Set (Radiology) | 3 | 03/16/2012 |
| ISO 14971:2007(RecognitionNumber 5-70) | AAMI / ANSI/ ISO | Medical Devices -Applications of RiskManagement to MedicalDevices | 2007 | 03/16/2012 |
| IEC 62304:2006(RecognitionNumber 13-32) | AAMI / ANSI/ IEC | Medical Device Software -Software Life CycleProcesses (Software /Informatics) | 2006 | 08/20/2012 |
Substantial Equivalence Analysis Conclusion:
Vital Images believes the Vitrea View software has a similar intended use, indications for use, principle of operation, and technological characteristics as the legally marketed, predicate device VitreaView (K150738). The added feature to allow for viewing of mammography for review and diagnosis is substantially equivalent to the feature in the reference device, McKesson Radiology, which was cleared by the FDA under K140909. Additionally, the feature to allow for viewing of digital breast tomosynthesis for review and diagnosis is substantially equivalent to the Phillips Intellispace Radiology system, which was cleared by the FDA under K111804.
Furthermore, the verification and validation testing performed demonstrate the subject device is as safe and effective as the predicate and reference devices and does not raise any different questions of safety and effectiveness. Therefore, Vital believes the addition of the support for diagnostic viewing of mammographic images and digital breast tomography images in the Vitrea View software does not alter the fundamental scientific technology, safety or intended use of the device.
Any noted minor differences have been explained and do not raise any different questions of safety or effectiveness when used as labeled. The implemented design controls, risk management activities, labeling, and performed verification and validation tests demonstrate the safety and efficacy of the subject device. Based on the comparison information provided above, Vital Images believes the subject device should be found substantially equivalent to the predicate device.
§ 892.2050 Medical image management and processing system.
(a)
Identification. A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.(b)
Classification. Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).